Adverum Biotechnologies, Inc. (ADVM) Earning

NASDAQ Currency in USD Disclaimer

$4.74

south_east -$0 (0%)
Day's range
$4.6
Day's range
$4.75

Adverum Biotechnologies, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 3 -$1.40 -$1.40 -$1.40
Q2 2024 3 -$1.47 -$1.47 -$1.47
Q3 2024 3 -$1.31 -$1.31 -$1.31
Q4 2024 5 -$1.48 -$1.09 -$1.36
Q1 2025 3 -$1.52 -$1.17 -$1.35
Q2 2025 2 -$1.41 -$1.41 -$1.41
Q3 2025 2 -$1.32 -$1.32 -$1.32
Q4 2025 2 -$1.23 -$1.23 -$1.23

Adverum Biotechnologies, Inc. Earnings Date And Information

Adverum Biotechnologies, Inc. last posted its earnings results on Monday, November 4th, 2024. The company reported $-1.3 earnings per share for the quarter, missing analysts' consensus estimates of $-1.2 by $0.1. The company had revenue of 1.00 M for the quarter and had revenue of 3.60 M for the year. Adverum Biotechnologies, Inc. has generated $-12 earnings per share over the last year ($-11.62 diluted earnings per share) and currently has a price-to-earnings ratio of -1.05. Adverum Biotechnologies, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based on prior year's report dates.

Adverum Biotechnologies, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
11/04/2024 Q3 2024 -$1.20 -$1.30 -0.1 $125,000 $1.00 M
08/12/2024 Q2 2024 -$1.27 -$0.89 0.38 $106,000 $0
05/09/2024 Q1 2024 -$1.28 -$1.50 -0.22 $0
03/18/2024 Q4 2023 -$2.80 -$2.34 0.46 $-3,600,000
11/09/2023 Q3 2023 -$3.00 -$3.26 -0.26 $0
08/10/2023 Q2 2023 -$3.20 -$3.13 0.07 $0
05/11/2023 Q1 2023 -$2.90 $3.60 M
03/30/2023 Q4 2022 -$3.20 -$3.28 -0.08 $0
11/10/2022 Q3 2022 -$3.20 -$0.40 2.8 $0
08/11/2022 Q2 2022 -$3.80 -$0.44 3.36 $0
05/12/2022 Q1 2022 -$3.40 -$0.38 3.02 $0
03/29/2022 Q4 2021 -$4.20 -$0.35 3.85 $-7,500,000
11/04/2021 Q3 2021 -$4.20 -$0.39 3.81 $0
08/05/2021 Q2 2021 -$3.70 -$0.45 3.25 $0
05/06/2021 Q1 2021 -$3.80 -$0.29 3.51 $7.50 M
03/01/2021 Q4 2020 -$3.20 -$0.39 2.81 $0
11/05/2020 Q3 2020 -$3.50 -$0.31 3.19 $76,667 $0
08/10/2020 Q2 2020 -$3.00 -$0.36 2.64 $76,667 $0
05/28/2020 Q1 2020 -$2.70 -$0.31 2.39 $0
03/12/2020 Q4 2019 -$3.10 -$0.26 2.84 $-250,000
 

Adverum Biotechnologies, Inc. Earnings: FAQ's

When is Adverum Biotechnologies, Inc.'s earnings date?

Adverum Biotechnologies, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, March 17th, 2025 based off last year's report dates.

How can I listen to Adverum Biotechnologies, Inc.'s earnings conference call?

The conference call for Adverum Biotechnologies, Inc.'s latest earnings report can be listened to online.

How can I read Adverum Biotechnologies, Inc.'s conference call transcript?

The conference call transcript for Adverum Biotechnologies, Inc.'s latest earnings report can be read online.

How much revenue does Adverum Biotechnologies, Inc. generate each year?

Adverum Biotechnologies, Inc. (:ADVM) has a recorded annual revenue of $3.60 M.

How much profit does Adverum Biotechnologies, Inc. generate each year?

Adverum Biotechnologies, Inc. (:ADVM) has a recorded net income of $3.60 M. Adverum Biotechnologies, Inc. has generated $-11.62 earnings per share over the last four quarters.

What is Adverum Biotechnologies, Inc.'s price-to-earnings ratio?

Adverum Biotechnologies, Inc. (:ADVM) has a price-to-earnings ratio of -1.05 and price/earnings-to-growth ratio is -0.04.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED